@Reuters
Reuters
5 days ago
A third member of a panel of outside advisers to the U.S. FDA has resigned in protest over the agency's decision to approve Biogen's Alzheimer's disease treatment despite the committee's recommendation against doing so https://t.co/1gH6DmJaqe https://t.co/tTQa8KjCKR
Tweet media one
7
45
62

Replies

@sqlserver20188
芸豆馅饺子好吃,很好吃
5 days ago
@Reuters Fucci should have done this when Trump insisted masks were not needed.
0
0
0
@TweetTDG
The Digital Gazette
5 days ago
@Reuters This decision doesn't remotely meet scientific standards for approval. It does, however, meet the desire to bilk desperate people and their insurance companies in order to generate C-Suite bonuses. Follow the money, especially when that conflicts with the science.
0
0
2
@onursal_nilufer
Nilufer Onursal
5 days ago
@Reuters Now This 🙄🤨
0
0
0